A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Generic Name | Trade Name | Designation Date | Designation | Orphan Drug Status | FDA Approval Status | Approved Indication | Marketing Approval Date | Exclusivity End Date | Contact Company | Contact Address 1 | Contact Address 2 | Contact City | Contact State | Contact Zip | Contact Country | CF Grid Key | Year of designation | Lag, designation to approval | |||||
2 | Diaziquone | n/a | 1983-11-10 | Treatment of primary brain malignancies (grade III and IV astrocytomas). | Designated/Withdrawn | N/A | N/A | Warner-Lambert Company | 2800 Plymouth Rd., P.O. Box 1047 | Ann Arbor | Michigan | 48106 | USA | 383 | 1983 | |||||||||
3 | Alpha-1-antitrypsin (recombinant DNA Origin) | n/a | 1984-01-01 | As supplementation therapy for alpha-1-antitrypsin deficiency in the ZZ phenotype population. | Designated/Withdrawn | N/A | N/A | Chiron Corporation | 4560 Horton Street | Emeryville | California | 94608 | USA | 283 | 1984 | |||||||||
4 | Altretamine | Hexalen | 1984-02-09 | Treatment of advanced adenocarcinoma of the ovary. | Designated/Approved | Approved for Orphan Indication | Single agent palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent based combination. | 1990-12-26 | 1997-12-26 | Medimmune Oncology, Inc. | One Tower Bridge | 100 Front St., Suite 400 | West Conshohocken | Pennsylvania | 19428 | USA | 983 | 1984 | 2512 | |||||
5 | Pentamidine isethionate | Pentam 300 | 1984-02-28 | Treatment of Pneumocystis carinii pneumonia. | Designated/Approved | Approved for Orphan Indication | 1984-10-16 | 1991-10-16 | Fujisawa USA, Inc. | 3 Parkway North Center | Deerfield | Illinois | 60015 | USA | 1083 | 1984 | 231 | |||||||
6 | Levocarnitine | Carnitor | 1984-02-28 | Treatment of genetic carnitine deficiency. | Designated/Approved | Approved for Orphan Indication | 1986-04-10 | 1993-04-10 | Leadiant Biosciences, Inc. | 9841 Washingtonian Blvd | Suite 500 | Gaithersburg | Maryland | 20878 | USA | 1384 | 1984 | 772 | ||||||
7 | Cromolyn sodium | Gastrocrom | 1984-03-08 | Treatment of mastocytosis. | Designated/Approved | Approved for Orphan Indication | 1989-12-22 | 1996-12-22 | Fisons Corporation | 755 Jefferson Rd., P.O. Box 1710 | Rochester | New York | 14603 | USA | 1183 | 1984 | 2115 | |||||||
8 | Bacitracin | Altracin | 1984-03-13 | Treatment of antibiotic-associated pseudomembranous enterocolitis caused by toxins A and B elaborated by Clostridium difficile. | Designated | N/A | N/A | A. L. Laboratories, Inc. | One Executive Drive | P.O. Box 1399 | Fort Lee | New Jersey | 7024 | USA | 1284 | 1984 | ||||||||
9 | Hemin | Panhematin | 1984-03-16 | Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria. | Designated/Approved | Approved for Orphan Indication | 1983-07-20 | 1990-07-20 | Abbott Laboratories | Diagnostics Division | Abbott Park | Illinois | 60064 | USA | 683 | 1984 | -240 | |||||||
10 | Ethanolamine oleate | Ethamolin | 1984-03-22 | Treatment of patients with esophageal varices that have recently bled, to prevent rebleeding. | Designated/Approved | Approved for Orphan Indication | 1988-12-22 | 1995-12-22 | QOL Medical | 4445 North Highway A1A, 241 | Vero Beach | Florida | 32963 | USA | 1484 | 1984 | 1736 | |||||||
11 | Botulinum toxin type A | Botox | 1984-03-22 | Treatment of strabismus and blepharospasms | Designated/Approved | Approved for Orphan Indication | Treatment of strabismus associated with dystonia in adults (patients 12 years of age and above) | 1989-12-29 | 1996-12-29 | Allergan, Inc. | 2525 Dupont Drive | P.O. Box 19534 | Irvine | California | 92713 | USA | 483 | 1984 | 2108 | |||||
12 | Botulinum toxin type A | Botox | 1984-03-22 | Treatment of strabismus and blepharospasms | Designated/Approved | Approved for Orphan Indication | Treatment of blepharospasm associated with dystonia in adults (patients 12 years of age and above) | 1989-12-30 | 1996-12-30 | Allergan, Inc. | 2525 Dupont Drive | P.O. Box 19534 | Irvine | California | 92713 | USA | 483 | 1984 | 2109 | |||||
13 | Epoprostenol | Flolan | 1984-03-29 | Replacement of heparin in patients requiring hemodialysis and who are at risk of hemmorrage | Designated/Withdrawn | N/A | N/A | Glaxo Wellcome Inc. | 5 Moore Drive | Research Triangle Park | North Carolina | 27709 | USA | 783 | 1984 | |||||||||
14 | Succimer | Chemet Capsules | 1984-05-09 | Treatment of lead poisoning in children. | Designated/Approved | Approved for Orphan Indication | 1991-01-30 | 1998-01-30 | Bock Pharmacal Company | P.O. Box 419056 | Saint Louis | Missouri | 63141 | USA | 1984 | 1984 | 2457 | |||||||
15 | Pegademase bovine | Adagen | 1984-05-29 | For enzyme replacement therapy for ADA deficiency in patients with severe combined immunodeficiency. | Designated/Approved | Approved for Orphan Indication | 1990-03-21 | 1997-03-21 | Sigma-tau Pharmaceuticals, Inc. | 9841 Washingtonian Blvd | Suite 500 | Gaithersburg | Maryland | 20878 | USA | 2084 | 1984 | 2122 | ||||||
16 | Monooctanoin | Moctanin | 1984-05-30 | For dissolution of cholesterol gallstones retained in the common bile duct. | Designated/Approved | Approved for Orphan Indication | 1985-10-31 | 1992-10-31 | Ethitek Pharmaceuticals, Inc. | 7855 Gross Point Road, Unit L | Skokie | Illinois | 60077 | USA | 2484 | 1984 | 519 | |||||||
17 | Clofazimine | Lamprene | 1984-06-11 | Treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum. | Designated/Approved | Approved for Orphan Indication | 1986-12-15 | 1993-12-15 | Novartis Pharmaceutical Corporation | 59 Route 10 | East Hanover | New Jersey | 7936 | USA | 2684 | 1984 | 917 | |||||||
18 | viloxazine HCL | Catatrol | 1984-06-11 | Treatment of cataplexy and narcolepsy | Designated/Withdrawn | N/A | N/A | Stuart Pharmaceuticals | Division of ICI Americas | Wilmington | Delaware | 19897 | USA | 2384 | 1984 | |||||||||
19 | Levocarnitine | Carnitor | 1984-07-26 | Treatment of primary and secondary carnitine deficiency of genetic origin. | Designated/Approved | Approved for Orphan Indication | Treatment of primary systemic carnitine deficiency. (approved 12/27/85) Treatment of secondary carnitine deficiency. (approved 12/16/92) | 1992-12-16 | 1999-12-16 | Leadiant Biosciences, Inc. | 9841 Washingtonian Blvd | Suite 500 | Gaithersburg | Maryland | 20878 | USA | 1584 | 1984 | 3065 | |||||
20 | Iodine 131 6B-iodomethyl-19-norcholesterol | n/a | 1984-08-01 | For use in adrenal cortical imaging. | Designated | N/A | N/A | David E. Kuhl, M.D. | University of Michigan Medical Center/1500 E. Med. | B1G412 /0028 University Hospital | Ann Arbor | Michigan | 48109 | USA | 2184 | 1984 | ||||||||
21 | chenodiol | Chenix | 1984-09-21 | For patients with radiolucent stones in well opacifying gallbladders, in whom elective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age | Designated/Approved | Approved for Orphan Indication | 1983-07-28 | 1990-07-28 | Solvay | 901 Sawyer Road | Marietta | Georgia | 30062 | USA | 3384 | 1984 | -421 | |||||||
22 | Quinacrine hydrochloride | n/a | 1984-10-17 | For prevention of recurrence of pneumothorax in patients at high risk of recurrence. | Designated/Withdrawn | N/A | N/A | Lyphomed, Inc. | 4184 | 1984 | ||||||||||||||
23 | Spiramycin | Rovamycine | 1984-10-17 | For symptomatic relief and parasitic cure of chronic cryptosporidiosis in patients with immunodeficiency. | Designated/Withdrawn | N/A | N/A | Rhone-Poulenc Rorer Pharmaceuticals | 500 Arcola Road | Collegeville | Pennsylvania | 19426 | USA | 3684 | 1984 | |||||||||
24 | Cyproterone acetate | Androcur | 1984-10-26 | Treatment of severe hirsutism. | Designated/Withdrawn | N/A | N/A | Berlex Laboratories, Inc. | 300 Fairfield Road | Wayne | New Jersey | 7470 | USA | 3884 | 1984 | |||||||||
25 | Epoprostenol | Cycloprostin | 1984-10-29 | Replacement of heparin in patients requiring hemodialysis and who are at increased risk of hemorrhage. | Designated/Withdrawn | N/A | N/A | Upjohn Company | 301 Henrietta Street | Kalamazoo | Michigan | 49001 | USA | 2884 | 1984 | |||||||||
26 | Pentamidine isethionate | n/a | 1984-10-29 | Treatment of Pneumocystis carinii pneumonia. | Designated | N/A | N/A | Aventis Behring L.L.C. | 1020 First Avenue | PO Box 61501 | King of Prussia | Pennsylvania | 19406 | USA | 3784 | 1984 | ||||||||
27 | Potassium citrate | Urocit-K | 1984-11-01 | 1. Prevention of calcium renal stones in patients with hypocitraturia 2. For avoidance of the complication of calcium stone formation in patients with uric lithiasis. | Designated/Approved | Approved for Orphan Indication | Prevention of recurring calcium conating stines associated with a deficiency in the urine. | 1985-08-07 | 1992-08-07 | University of Texas Health Science Center at Dallas | 5323 Harry Hines Blvd | Dallas | Texas | 75235 | USA | 9685 | 1984 | 279 | ||||||
28 | Potassium citrate | Urocit-K | 1984-11-01 | Prevention of uric acid nephrolithiasis. | Designated/Approved | Approved for Orphan Indication | 1985-08-30 | 1992-08-30 | University of Texas Health Science Center at Dallas | 5323 Harry Hines Blvd | Dallas | Texas | 75235 | USA | 2784 | 1984 | 302 | |||||||
29 | Digoxin immune FAB (Ovine) | Digibind | 1984-11-01 | Treatment of potentially life threatening digitalis intoxication in patients who are refractory to management by conventional therapy. | Designated/Approved | Approved for Orphan Indication | 1986-04-22 | 1993-04-22 | Glaxo Wellcome Inc. | 5 Moore Drive | Research Triangle Park | North Carolina | 27709 | USA | 2584 | 1984 | 537 | |||||||
30 | Teniposide | Vumon For Injection | 1984-11-01 | Treatment of refractory childhood acute lymphocytic leukemia. | Designated/Approved | Approved for Orphan Indication | Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents. | 1992-07-14 | 1999-07-14 | Bristol-Myers Squibb Pharmaceutical Research Institute | 5 Research Parkway | P.O. Box 5100 | Wallingford | Connecticut | 6492 | USA | 883 | 1984 | 2812 | |||||
31 | L-5 Hydroxytrytophan | n/a | 1984-11-01 | Treatment of postanoxic intention myoclonus. | Designated | N/A | N/A | Watson Laboratories, Inc. | 33 Ralph Avenue | P.O. Box 30 | Copiaque | New York | 11726 | USA | 3984 | 1984 | ||||||||
32 | Urogastrone | n/a | 1984-11-01 | For acceleration of corneal epithelial regeneration and healing of stromal incisions from corneal transplant surgery. | Designated | N/A | N/A | Chiron Vision | 500 Iolab Drive | Claremont | California | 91711 | USA | 1684 | 1984 | |||||||||
33 | Selegiline HCl | Eldepryl | 1984-11-07 | As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism. | Designated/Approved | Approved for Orphan Indication | 1989-06-05 | 1996-06-05 | Somerset Pharmaceuticals, Inc. | 400 Morris Ave., Suite 7s | Denville | New Jersey | 7834 | USA | 583 | 1984 | 1671 | |||||||
34 | Antimelanoma Antibody XMMME-001-DTPA 111 Indium | Antimelanoma Antibody Xmmme-001-Dtpa 111 Indium | 1984-11-14 | Diagnostic use in imaging systemic and nodal melanoma metastasis. | Designated/Withdrawn | N/A | N/A | Xoma Corporation | 2910 Seventh Street | Berkeley | California | 94710 | USA | 3484 | 1984 | |||||||||
35 | Antimelanoma Antibody XMMME-001-RTA | Antimelanoma Antibody Xmmme-001-Rta | 1984-11-14 | Treatment of stage III melanoma not amenable to surgical resection. | Designated/Withdrawn | N/A | N/A | Xoma Corporation | 2910 Seventh Street | Berkeley | California | 94710 | USA | 3584 | 1984 | |||||||||
36 | Iobenguane Sulfate I 131 | n/a | 1984-11-14 | For use as a diagnostic adjunct in patients with pheochromocytoma. | Designated/Approved/Withdrawn | Adjunctive diagnostic agent in the localization of primary or metastatic pheochromocytomas. | N/A | 2001-03-25 | University of Michigan | UH B1 H410/0028 | 1500 E. Medical Center Drive | Ann Arbor | Michigan | 48109 | USA | 2284 | 1984 | |||||||
37 | Antithrombin III (human) | Thrombate Iii | 1984-11-26 | For replacement therapy in congenital deficiency of AT-III for prevention and treatment of thrombosis and pulmonary emboli. | Designated/Approved | Approved for Orphan Indication | 1991-12-30 | 1998-12-30 | Bayer Corporation | Pharmaceutical Division, Biological Products | 400 Morgan Lane | New Haven | Connecticut | 6516 | USA | 4084 | 1984 | 2590 | ||||||
38 | Alpha1-proteinase inhibitor (human) | Prolastin | 1984-12-07 | For replacement therapy in the alpha-1-proteinase inhibitor congenital deficiency state. | Designated/Approved | Approved for Orphan Indication | For chronic replacement therapy of individuals having congenital deficiency of alpha1- proteinase inhibitor with clinically demonstrable panacinar emphysema. | 1987-12-02 | 1994-12-02 | Bayer Corporation | Pharmaceutical Division, Biological Products | 400 Morgan Lane | New Haven | Connecticut | 6516 | USA | 3084 | 1984 | 1090 | |||||
39 | Amsacrine | Amsidyl | 1984-12-07 | Treatment of acute adult leukemia. | Designated/Withdrawn | N/A | N/A | Warner-Lambert Company | 2800 Plymouth Road | Ann Arbor | Michigan | 48106 | USA | 4584 | 1984 | |||||||||
40 | Sodium monomercaptoundecahydro-closo-dodecaborate | n/a | 1984-12-18 | For use in conjunction with a thermal or epithermal neutron beam in boron nuclear capture therapy of glioblastoma multiforme. | Designated/Withdrawn | N/A | N/A | Theragenics Corporation | 4284 | 1984 | ||||||||||||||
41 | Trientine HCl | Syprine | 1984-12-24 | Treatment of patients with Wilson's disease who are intolerant, or inadequately responsive to penicillamine. | Designated/Approved | Approved for Orphan Indication | 1985-11-08 | 1992-11-08 | Merck Sharp & Dohme Research | Division Of Merck And Company | West Point | Pennsylvania | 19486 | USA | 4884 | 1984 | 319 | |||||||
42 | Protirelin injection | n/a | 1985-01-10 | Treatment of amyotrophic lateral sclerosis. | Designated/Withdrawn | N/A | N/A | Abbott Laboratories | 200 Abbott Park Road | Abbott Park | Illinois | USA | 5184 | 1985 | ||||||||||
43 | Flumecinol | Zixoryn | 1985-01-15 | Treatment of hyperbilirubinemia in newborn infants unresponsive to phototherapy. | Designated/Withdrawn | N/A | N/A | Farmacon, Inc. | Post House, Suite 213 | 1720 Post Road East | Westport | Connecticut | 6880 | USA | 2984 | 1985 | ||||||||
44 | factor XIII concentrate (human) | Corifact | 1985-01-16 | Treatment of congenital factor XIII deficiency | Designated/Approved | Approved for Orphan Indication | For the routine prophylactic treatment of congenital factor XIII deficiency | 2011-02-17 | 2018-02-17 | CSL Behring LLC | 1020 First Ave. | PO Box 61501 | King of Prussia | Pennsylvania | 19406 | USA | 4484 | 1985 | 9528 | |||||
45 | factor XIII concentrate (human) | Corifact | 1985-01-16 | Treatment of congenital factor XIII deficiency | Designated/Approved | Approved for Orphan Indication | Peri-operative management of surgical bleeding in adult and pediatric patients with congenital Factor XIII deficiency. | 2013-01-24 | 2020-01-24 | CSL Behring LLC | 1020 First Ave. | PO Box 61501 | King of Prussia | Pennsylvania | 19406 | USA | 4484 | 1985 | 10235 | |||||
46 | physostigmine salicylatephysostigmine salicylate | n/a | 1985-01-16 | Treatment of Friedreich's and other inherited ataxias. | Designated/Withdrawn | N/A | N/A | Forest Pharmaceuticals.3-.3-.30 6 | 150 East 58th Street | New York | New York | 10155 | USA | 183 | 1985 | |||||||||
47 | Gamma-hydroxybutyric acid | n/a | 1985-01-22 | Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleep paralysis, hypnagogic hallucinations, and automatic behavior. | Designated/Withdrawn | N/A | N/A | Sigma Chemical Company | 5384 | 1985 | ||||||||||||||
48 | Levomethadyl acetate hydrochloride | Orlaam | 1985-01-24 | Treatment of heroin addicts suitable for maintenance on opiate agonists. | Designated/Approved | Approved for Orphan Indication | For the management of opiate dependence. | 1993-07-09 | 2000-07-09 | Biodevelopment Corporation | 8180 Greensboro Drive, Suite 1000 | McLean | Virginia | 22102 | USA | 4784 | 1985 | 3088 | ||||||
49 | Erwinia L-asparaginase | n/a | 1985-01-25 | For use as an alternative to E. coli asparaginase in those situations where repeat courses of asparaginase therapy for acute lymphoblastic leukemia are required or where allergic reactions force the discontinuance of the E. coli preparation. | Designated/Withdrawn | N/A | N/A | Lyphomed, Inc. | 4684 | 1985 | ||||||||||||||
50 | Antithrombin III (human) | Atnativ | 1985-02-08 | For the treatment of patients with hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism. | Designated/Approved | Approved for Orphan Indication | 1989-12-13 | 1996-12-13 | Pharmacia & Upjohn AB | Lindhagensgatan 133 | Stockholm | Sweden | 5084 | 1985 | 1769 | |||||||||
51 | Antipyrine Test | n/a | 1985-02-21 | For use as an index of hepatic drug-metabolizing capacity. | Designated/Withdrawn | N/A | N/A | Upsher-Smith Laboratories, Inc | 4905 23rd Avenue North | Minneapolis | Minnesota | 55447 | USA | 5284 | 1985 | |||||||||
52 | Epidermal growth factor (human) | n/a | 1985-03-06 | For promotion of cutaneous wound healing in extreme burn treatment protocols. | Designated/Withdrawn | N/A | N/A | Ethicon, Inc. | P.O. Box 151 | Somerville | New Jersey | 8876 | USA | 5485 | 1985 | |||||||||
53 | Superoxide dismutase (human) | n/a | 1985-03-06 | For protection of donor organ tissue from damage or injury mediated by oxygen-derived free radicals that are generated during the necessary periods of ischemia (hypoxia, anoxia), and especially reperfusion, associated with the operative procedure. | Designated | N/A | N/A | Pharmacia-Chiron Partnership | 4560 Horton Street | Emeryville | California | 94608 | USA | 5985 | 1985 | |||||||||
54 | Naltrexone HCl | Trexan | 1985-03-11 | For blockade of the pharmacological effects of exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified formerly opioid-dependent individuals. | Designated/Approved | Approved for Orphan Indication | 1984-11-30 | 1991-11-30 | DuPont Pharmaceuticals | E.I. Du Pont De Nemours & Co. | Wilmington | Delaware | 19898 | USA | 6085 | 1985 | -101 | |||||||
55 | Alglucerase injection | Ceredase | 1985-03-11 | For replacement therapy in patients with Gaucher's disease type I. | Designated/Approved | Approved for Orphan Indication | Long-term enzyme replacement therapy for children, adolescents and adult patients with a confirmed diagnosis of Type I Gaucher disease who exhibit signs and symptoms that are severe enough to result in one or more of the following conditions: a) moderate-to-severe anemia; b) thrombocytopenia with bleeding tendency; c) bone disease; d) significant hepatomegaly or splenomegaly. | 1991-04-05 | 1998-04-05 | Genzyme Corporation | One Kendall Square | Cambridge | Massachusetts | 2139 | USA | 5585 | 1985 | 2216 | ||||||
56 | Digoxin immune fab(ovine) | Digidote | 1985-03-11 | Treatment of life-threatening acute cardiac glycoside intoxication manifested by conduction disorders, ectopic ventricular activity and (in some cases) hyperkalemia. | Designated | N/A | N/A | Boehringer Mannheim Corp. | 1301 Piccard Drive | Rockville | Maryland | 20850 | USA | 5685 | 1985 | |||||||||
57 | Oxymorphone | Numorphan H.P. | 1985-03-19 | For relief of severe intractable pain in narcotic-tolerant patients. | Designated | N/A | N/A | DuPont Merck Pharmaceutical Company | P.O. Box 80027 | Wilmington | Delaware | 19880 | USA | 6185 | 1985 | |||||||||
58 | Tretinoin | n/a | 1985-04-15 | Treatment of squamous metaplasia of the ocular surface epithelia (conjunctiva and/or cornea) with mucous deficiency and keratinization. | Designated | N/A | N/A | Hannan Ophthalmic Marketing Services, Inc | 34 Sherrill Rd. | Marshfield | Massachusetts | 2050 | USA | 5785 | 1985 | |||||||||
59 | calfactant | Infasurf | 1985-06-07 | Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants. | Designated/Approved | Approved for Orphan Indication | Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants. | 1998-07-01 | N/A | ONY, Inc. | 1576 Sweet Home Road | Amherst | New York | 14228 | USA | 6285 | 1985 | 4772 | ||||||
60 | Gancyclovir | n/a | 1985-06-07 | Treatment of severe human cytomegalovirus infections in specific immunosuppressed patient populations. | Designated/Withdrawn | N/A | N/A | Burroughs Wellcome Company | 3030 Cornwallis Road | P.O. Box 12700 | Research Triangle Park | North Carolina | 27709 | USA | 5885 | 1985 | ||||||||
61 | Anagrelide | Agrylin | 1985-06-11 | Treatment of polycythemia vera. | Designated | N/A | N/A | Roberts Pharmaceutical Corp. | Meridian Center II | Four Industrial Way West | Eatontown | New Jersey | 7724 | USA | 6985 | 1985 | ||||||||
62 | Prednimustine | Sterecyt | 1985-06-17 | Treatment of malignant non-Hodgkin's lymphomas. | Designated/Withdrawn | N/A | N/A | Pharmacia Inc. | P.O. Box 16529 | Columbus | Ohio | 43216 | USA | 6685 | 1985 | |||||||||
63 | Midodrine HCl | Amatine | 1985-06-21 | Treatment of patients with symptomatic orthostatic hypotension. | Designated/Approved | Approved for Orphan Indication | Treatment of symptomatic orthostatic hypotension. | 1996-09-06 | 2003-09-06 | Shire | 725 Chesterbrook Blvd | Wayne | Pennsylvania | 19087 | USA | 7585 | 1985 | 4095 | ||||||
64 | Antithrombin III (human) concentrate IV | Kybernin P | 1985-07-02 | For prophylaxis and treatment of thromboembolic episodes in patients with genetic AT-III deficiency. | Designated/Withdrawn | N/A | N/A | CSL Behring | 1020 First Ave. | PO Box 61501 | King of Prussia | Pennsylvania | 19406 | USA | 7185 | 1985 | ||||||||
65 | Defibrotide | n/a | 1985-07-05 | Treatment of thrombotic thrombocytopenic purpura. | Designated | N/A | N/A | Crinos International | Via Belvedere 1 | Villa Guardia, Italy | 22079 | USA | 7285 | 1985 | ||||||||||
66 | zidovudine | Retrovir | 1985-07-17 | Treatment of AIDS | Designated/Approved | Approved for Orphan Indication | Management of certain adult patients with symptomatic HIV infection (AIDS and advanced ARC) who have a history of cytologically confirmed Pneumocytis carinii pneumonia (PCP) or an absolute CD4 (T4 helper/induccer) lymphocyte count of less than 200/mm in the peripheral blood before therapy is begun | 1987-03-19 | 1994-03-19 | Glaxo Wellcome Inc. | 5 Moore Drive | Research Triangle Park | North Carolina | 27709 | USA | 8185 | 1985 | 610 | ||||||
67 | ammonium 21-tungsto-9-antimoniate | n/a | 1985-07-17 | Treatment of acquired immunodeficiency syndrome. | Designated/Withdrawn | N/A | N/A | Rhone-Poulenc Rorer Pharm. | 500 Arcola Road | Collegeville | Pennsylvania | 19426 | USA | 7785 | 1985 | |||||||||
68 | Cromolyn sodium 4% ophthalmic solution | Opticrom 4% Ophthalmic Solution | 1985-07-24 | Treatment of vernal keratoconjunctivitis. | Designated/Approved | Approved for Orphan Indication | 1984-10-03 | 1991-10-03 | Fisons Corporation | 755 Jefferson Rd. | P.O. Box 1710 | Rochester | New York | 14603 | USA | 8285 | 1985 | -294 | ||||||
69 | Trimetrexate glucuronate | n/a | 1985-07-25 | Treatment of pancreatic adenocarcinoma. | Designated/Withdrawn | N/A | N/A | Medimmune Oncology, Inc. | One MedImmune Way | Gaithersburg | Maryland | 20878 | USA | 8385 | 1985 | |||||||||
70 | Pentosan polysulfate sodium | Elmiron | 1985-08-07 | Treatment of interstitial cystitis. | Designated/Approved | Approved for Orphan Indication | Relief of bladder pain or discomfort associated with interstitial cystitis. | 1996-09-26 | 2003-09-26 | Alza Corporation | 950 Page Mill Rd. | PO Box 10950 | Palo Alto | California | 94303 | USA | 1784 | 1985 | 4068 | |||||
71 | ifosfamide | n/a | 1985-08-07 | Treatment of soft tissue and bone sarcomas | Designated | N/A | N/A | Bristol-Myers Squibb Company | P.O. Box 4000 | Mail Stop D12-02 | Princeton | New Jersey | 8543 | USA | 8585 | 1985 | ||||||||
72 | Pentastarch | Pentaspan | 1985-08-28 | As an adjunct in leukapheresis to improve the harvesting and increase the yield of leukocytes by centrifugal means. | Designated/Approved | Approved for Orphan Indication | 1987-05-19 | 1994-05-19 | DuPont Pharmaceuticals | E.I. Du Pont De Nemours & Co. | Wilmington | Delaware | 19898 | USA | 8085 | 1985 | 629 | |||||||
73 | tranexamic acid | Cyklokapron | 1985-09-09 | Treatment of hereditary angioneurotic edema | Designated/Approved/Withdrawn | Treatment of patients with hemophilia for short term use (2 to 8 days) before and after tooth extraction to reduce or prevent hemorrhage abd reduce the need for replacement therapy | N/A | 1993-12-30 | Pharmacia Inc. | P.O. Box 16529 | Columbus | Ohio | 43216 | USA | 8885 | 1985 | ||||||||
74 | Rifampin, isoniazid, pyrazinamide | Rifater | 1985-09-12 | For the short-course treatment of tuberculosis. | Designated/Approved | Approved for Orphan Indication | Short-course treatment of tuberculosis. | 1994-05-31 | 2001-05-31 | Hoechst Marion Roussel | P.O. Box 9627 | Kansas City | Missouri | 64134 | USA | 6585 | 1985 | 3183 | ||||||
75 | Epoprostenol | Flolan | 1985-09-25 | Treatment of primary pulmonary hypertension. | Designated/Approved | Approved for Orphan Indication | Long-term intravenous treatment of primary pulmonary hypertension in NYHA Class III and Class IV patients. | 1995-09-20 | 2002-09-20 | Glaxo Wellcome Inc. | 5 Moore Drive | Research Triangle Park | North Carolina | 27709 | USA | 8785 | 1985 | 3647 | ||||||
76 | Hydroxycobalamin/sodium thiosulfate | n/a | 1985-10-04 | Treatment of severe acute cyanide poisoning. | Designated/Withdrawn | N/A | N/A | Hall, Alan H., M.D. | Mile 5.0 Pass Creek Road | PO Box 24 | Elk Mountain | Wyoming | 82324 | USA | 9585 | 1985 | ||||||||
77 | Methotrexate sodium | Methotrexate | 1985-10-21 | Treatment of osteogenic sarcoma. | Designated/Approved | Approved for Orphan Indication | For the use of high dose methotrexate with leucovorin rescue in patients with non-metastatic osteosarcoma who have undergone surgical resection or amputation for the primary tumor. | 1988-04-07 | 1995-04-07 | Lederle Laboratories | Division of American Cyanamid Company | 401 N. Middletown Road | Pearl River | New York | 10965 | USA | 9985 | 1985 | 899 | |||||
78 | Ganciclovir sodium | Cytovene | 1985-10-31 | Treatment of cytomegalovirus retinitis in immunocompromised patients with AIDS. | Designated/Approved/Withdrawn | N/A | 1996-06-23 | Syntex (USA), Inc. | 3401 Hillview Avenue | Palo Alto | California | 94304 | USA | 7985 | 1985 | |||||||||
79 | Monoclonal antiendotoxin antibody XMMEn-0e5 | n/a | 1985-11-04 | Treatment of patients with gram-negative sepsis which has progressed to shock. | Designated/Withdrawn | N/A | N/A | Pfizer, Inc. | 235 East 42nd Street | New York | New York | 10017 | USA | 6885 | 1985 | |||||||||
80 | Zinc acetate | Galzin | 1985-11-06 | Treatment of Wilson's disease. | Designated/Approved | Approved for Orphan Indication | For maintenance treatment of patients with Wilson's disease who have been initially treated with a chelating agent. | 1997-01-28 | 2004-01-28 | Lemmon Company | 1510 Delp Drive | Kulpsville | Pennsylvania | 19443 | USA | 11185 | 1985 | 4101 | ||||||
81 | Mesna | Mesnex | 1985-11-14 | For use as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. | Designated/Approved | Approved for Orphan Indication | 1988-12-30 | 1995-12-30 | Degussa Corporation | 65 Challenger Road | Ridgefield Park | New Jersey | 7660 | USA | 8685 | 1985 | 1142 | |||||||
82 | Allopurinol riboside | n/a | 1985-12-04 | 1. Treatment of Chagas' disease 2. Treatment of cutaneous and visceral leishmaniasis | Designated/Withdrawn | N/A | N/A | Burroughs Wellcome Company | 3030 Cornwallis Road | P.O. Box 12700 | Research Triangle Park | North Carolina | 27709 | USA | 10685 | 1985 | ||||||||
83 | Somatrem for injection | Protropin | 1985-12-09 | 1. Long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion (prevalence 15,000) 2. Treatment of short stature associated with Turner's syndrome (prevalence 8000). | Designated/Approved | Approved for Orphan Indication | 1985-10-17 | 1992-10-17 | Genentech, Inc. | 1 DNA Way | South San Francisco | California | 94080 | USA | 10785 | 1985 | -53 | |||||||
84 | Rifampin | Rifadin I.V. | 1985-12-09 | For antituberculosis treatment where use of the oral form of the drug is not feasible. | Designated/Approved | Approved for Orphan Indication | 1989-05-25 | 1996-05-25 | Hoechst Marion Roussel | P.O. Box 9627 | Kansas City | Missouri | 64134 | USA | 7685 | 1985 | 1263 | |||||||
85 | Colchicine | n/a | 1985-12-09 | For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis. | Designated/Withdrawn | N/A | N/A | Pharmacontrol Corporation | 661 Palisade Ave., P.O. Box 931 | Englewood Cliffs | New Jersey | 7632 | USA | 11085 | 1985 | |||||||||
86 | Antithrombin III human | Antithrombin Iii Human | 1986-01-02 | Preventing or arresting episodes of thrombosis in patients with congenital AT-III deficiency and/or to prevent the occurrence of thrombosis in patients with AT-III deficiency who have undergone trauma or who are about to undergo surgery or parturition. | Designated | N/A | N/A | American National Red Cross | 9312 Old Georgetown Road | Bethesda | Maryland | 20814 | USA | 11485 | 1986 | |||||||||
87 | flunarizine | Sibelium | 1986-01-06 | Treatment of alternating hemiplegia. | Designated | N/A | N/A | Janssen Research Foundation | P.O. Box 200 | Titusville | New Jersey | 8560 | USA | 9485 | 1986 | |||||||||
88 | Guanethidine monosulfate | Ismelin | 1986-01-06 | Treatment of moderate to severe reflex sympathetic dystrophy and causalgia. | Designated/Withdrawn | N/A | N/A | Novartis Pharmaceuticals Corporation | 59 Route 10 | East Hanover | New Jersey | 7936 | USA | 6385 | 1986 | |||||||||
89 | Tiopronin | Thiola | 1986-01-17 | Prevention of cystine nephrolithiasis in patients with homozygous cystinuria. | Designated/Approved | Approved for Orphan Indication | 1988-08-11 | 1995-08-11 | Pak, Charles Y.C. M.D. | The University of Texas Health Scienc Center at Da | 5323 Harry Hines Boulevard | Dallas | Texas | 75235 | USA | 12386 | 1986 | 937 | ||||||
90 | Benzoate and phenylacetate | Ucephan | 1986-01-21 | For adjunctive therapy in the prevention and treatment of hyperammonemia in patients with urea cycle enzymopathy due to carbamylphosphate synthetase, ornithine, transcarbamylase, or argininosuccinate synthetase deficiency. | Designated/Approved | Approved for Orphan Indication | 1987-12-23 | 1994-12-23 | ImmunexImmunex | 2525 McGaw Avenue | P.O. Box 19791 | Irvine | California | 92623 | USA | 11385 | 1986 | 701 | ||||||
91 | Anti pan T lymphocyte monoclonal antibody | Anti-T Lymphocyte Immunotoxin Xmmly-H65-Rta | 1986-01-29 | 1. For ex-vivo treatment to eliminate mature T cells from potential bone marrow grafts 2. For in-vivo treatment of bone marrow recipients to prevent graft rejection and graft versus host disease. | Designated/Withdrawn | N/A | N/A | Xoma Corporation | 2910 Seventh Street | Berkeley | California | 94710 | USA | 10985 | 1986 | |||||||||
92 | Beractant | Survanta Intratracheal Suspension | 1986-02-05 | Treatment of neonatal respiratory distress syndrome | Designated/Approved | Approved for Orphan Indication | Treatment of ("rescue") of premature infants with RDS confirmed by x-ray and requiring mechanical ventilation | 1991-07-01 | 1998-07-01 | Ross Laboratories | 625 Cleveland Avenue | Columbus | Ohio | 43215 | USA | 10885 | 1986 | 1972 | ||||||
93 | Beractant | Survanta Intratracheal Suspension | 1986-02-05 | Treatment of neonatal respiratory distress syndrome | Designated/Approved | Approved for Orphan Indication | Prevention of RDS (hyaline membrane disease) in premature infants less than 1250 grams birthweight or with evidence of surfactant deficiency | 1991-07-02 | 1998-07-02 | Ross Laboratories | 625 Cleveland Avenue | Columbus | Ohio | 43215 | USA | 10885 | 1986 | 1973 | ||||||
94 | Potassium citrate and citric acid | n/a | 1986-02-14 | For the dissolution and control of uric acid and cysteine calculi in the urinary tract. | Designated/Withdrawn | N/A | N/A | Willen Drug Company | 9785 | 1986 | ||||||||||||||
95 | Terlipressin | Glypressin | 1986-03-06 | Treatment of bleeding esophageal varices. | Designated | N/A | N/A | Ferring Pharmaceuticals Inc. | 100 Interpace Parkway | Parsippany-Troy Hills | New Jersey | 7054 | USA | 11785 | 1986 | |||||||||
96 | Etidronate disodium | Didronel | 1986-03-21 | Treatment of hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration. | Designated/Approved | Approved for Orphan Indication | 1987-04-21 | 1994-04-21 | MGI Pharma, Inc. | 5775 West Old Shakopee Rd. | Suite 100 | Bloomington | Minnesota | 55437 | USA | 12185 | 1986 | 396 | ||||||
97 | Diethyldithiocarbamate | Imuthiol | 1986-04-03 | Treatment of AIDS. | Designated | N/A | N/A | Connaught Laboratories | Route 611, P.O. Box 187 | Swiftwater | Pennsylvania | 18370 | USA | 13286 | 1986 | |||||||||
98 | Epoetin alfa | Epogen | 1986-04-10 | Treatment of anemia associated with end stage renal disease. | Designated/Approved | Approved for Orphan Indication | Treatment of anemia associated with chronic renal failure, including patients on dialysis (end stage renal disesae) and patients not on dialysis | 1989-06-01 | 1996-06-01 | Amgen, Inc. | 1840 Dehavilland Drive | Thousand Oaks | California | 91320 | USA | 12486 | 1986 | 1148 | ||||||
99 | Eflornithine HCl | Ornidyl | 1986-04-18 | Treatment of Pneumocystis carinii pneumonia in AIDS patients. | Designated/Withdrawn | N/A | N/A | Marion Merrell Dow, Inc. | P.O. Box 9627 | Kansas City | Missouri | 64134 | USA | 13686 | 1986 | |||||||||
100 | Eflornithine HCl | Ornidyl | 1986-04-23 | Treatment of Trypanosoma brucei gambiense infection (sleeping sickness). | Designated/Approved | Approved for Orphan Indication | 1990-11-28 | 1997-11-28 | Hoechst Marion Roussel | P.O. Box 9627 | Kansas City | Missouri | 64134 | USA | 13586 | 1986 | 1680 |